Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


25th International Congress on Pharmaceutical Biotechnology

Amsterdam, Netherlands

Priti J Mehta

Department of Pharmaceutical Analysis, Institute of Pharmacy, Nirma University, Gujarat, India


Dr. Priti Mehta, Professor of Pharmaceutical Analysis at Institute of Pharmacy, Nirma University, has more than 20 years of teaching, Research and industrial experience. She is pioneer in starting post graduate program of Pharmaceutical Regulatory affairs in Institute of Pharmacy. Her area of expertise encompass stability studies of drugs, Impurity profiling, elucidation of degradation pathways of drugs, isolation and characterization of active moiety from plant and marine seaweeds, bioequivalence and bioavailability studies, development of long acting formulations, effects of radiation exposure on medicines, development of radioprotectors etc. She is pioneer in getting interdisciplinary research grants at Nirma University. Currently Dr Mehta is working on many government funded research projects worth of more than 10 million She is mentor of Women Scientist under WOS-A scheme of DST. Under her guidance many student got research fellowship from CSIR, INSPIRE, ICMR etc. Dr Mehta has published number of research papers and review articles in peer reviewed scientific Journals. Dr. Mehta has delivered guest lectures at various Institutions during seminars, workshops and staff development program. She has rendered professional services to leading Universities at various capacities. Her research students won scientific poster awards at national forums. She is a recipient of many national awards in India. Recently, she conferred prestigious APTI woman of the year 2018 award by Association of Pharmaceutical Teachers of India.


Abstract : Biosimilars: Comparative evaluation of Regulatory requirements of selected countries